MedPath
FDA Approval

Cleviprex

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 9, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Clevidipine(0.5 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fresenius Kabi Austria GmbH

Fresenius Kabi Austria GmbH

303448575

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cleviprex

Product Details

NDC Product Code
18124-011
Application Number
NDA022156
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
December 28, 2018
SOYBEAN OILInactive
Code: 241ATL177AClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
EGG PHOSPHOLIPIDSInactive
Code: 1Z74184RGVClass: IACT
OLEIC ACIDInactive
Code: 2UMI9U37CPClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 19O2GP3B7QClass: ACTIBQuantity: 0.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath